ESCMID Collaborative Centre
Koç University İşbank Center for Infectious Diseases
KUISCID-SYMPOSIUM
COVID-19: Our Experiences,
Take-home messages, Contributions
KUISCID
Scientists Met in İstanbul
KUISCID
We present our research output and news about our activities in monthly newsletter.
KUISCID
What is a Biosafety Level 3 Laboratory (BSL-3)?
Research Areas
Pathogens
We perform research in virology, bacteriology, and mycology that pose a public health threat.
Diseases
We search the response of the body to the microorganisms, investigate unknown diseases that could be of infectious in origin.
Diagnostics
We aim to develop easy-to-use, cheap, and accessible diagnostic tests for infectious diseases.
Treatment
We do more than repurposing the existing drugs with an interdisciplinary effort.
Infection Control
We aim to produce creative scientific solutions for infection control.
Pathogens
We perform research in virology, bacteriology, and mycology that pose a public health threat.
Diseases
We search the response of the body to the microorganisms, investigate unknown diseases that could be of infectious in origin.
Diagnostics
We aim to develop easy-to-use, cheap, and accessible diagnostic tests for infectious diseases.
Treatment
We do more than repurposing the existing drugs with an interdisciplinary effort.
Infection Control
We aim to produce creative scientific solutions for infection control.
Mission
Our mission is to lead a wide spectrum of scientific research to understand, treat, and prevent infectious diseases. In doing so, we aim to form a bridge in between the laboratory bench and clinical level of findings.
Infrastructure
NEWSLatest News from
Center For Infectious Diseases
JULY 29, 2023
PUBLICATION
Infectious Diseases After Devastating Disasters: Threats and Precautions
The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023, related to disease monitoring and providing solutions accordingly, was published in The Lancet Infectious Diseases.
JULY 29, 2023
PUBLICATION
Pandemic, Vaccination and Risk Groups: A Multi-Centered Study
KUISCID researchers have completed their study “BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac” and published it in Viruses Journal.
9 JUNE 2021
Hybrid Symposium; “Crimean Congo Hemorrhagec Fever”
You are invited to our Hybrid Symposium of Crimean-Congo Haemorrhagic Fever on 9th of June 2021 at 14:00. The symposium will be broadcasted live on Hitit Kurumsal Youtube page.
12 MARCH 2021
Web Symposium
The web symposium “COVID-19: One Year Of Experience and Beyond”, organized by our center, will take place on March 12, 2021 between 13:00 and 16:00.